jamiebell

127 POSTS 0 COMMENTS

phenox expands acute ischaemic stroke portfolio with global launch of pRESET...

phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...

Biomodex launches synthetic clot product for neurovascular training

Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...

Study indicates safety and efficacy of remote electrical neuromodulation in chronic...

remote electrical neuromodulation migraine
Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...

North Carolina updates stroke triage and transport protocol

North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...

Neuvotion secures more than US$1 million in seed funding to commercialise...

Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...

MindMaze partners with Royal Buckinghamshire Hospital to bring novel stroke rehab...

mindpod uk
MindMaze Healthcare has announced the first UK partnership for its novel MindPod platform to target cognitive and motor restoration in stroke patients. This new partnership...

NeuroNews’ top 10 most popular stories of September 2021

Highlights from this year's European Stroke Organisation Conference (ESOC 2021; 1–3 September, virtual), Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021;...

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

imperative zoom trial
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

neurovasc envi-sr trial china
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...

Stroke study reveals optimal timing and intensity for arm and hand...

stroke rehabilitation study
A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...

High-frequency SCS takes the stage to relieve chronic pain from diabetic...

scs diabetic neuropathy
Following the recent approval of the Senza system (Nevro) by the US Food and Drug Administration (FDA), Erika A Petersen (Little Rock, USA) discusses the...

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...

Indian health ministry approves Exablate Neuro focused ultrasound platform

exablate neuro india
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...

Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...

medtronic pipeline flex recall
Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...

FAST SCS innovation producing results “rarely seen before” in the world...

This advertorial is sponsored by Boston Scientific and is only intended for readers in Europe. Fast-acting sub-perception therapy (FAST™)—a novel innovation in the field of...

NeuroOne successfully completes feasibility study of Evo ablation electrode

Evo ablation electrode
NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...

LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...

evt neuroprotection
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...

Else Charlotte Sandset

else charlotte sandset
Else Charlotte Sandset is a consultant neurologist in the Stroke Unit of the Department of Neurology at Oslo University Hospital, and chair of the...

Rhaeos awarded US$4 million NIH grant to expand sensor technology for...

Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...

ESMINT 2021: COATING study “badly needed” to assess surface modification of...

coating study phenox
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...

Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...

neuros quest study
Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...

Study indicates efficacy of hyperbaric oxygen therapy in reversing Alzheimer’s activators

A new study, published in the peer-reviewed medical journal Aging, marks the first time non-pharmaceutical clinical exploration has proved efficacy in reversing the main...

Novel teleproctoring platform successfully used for neuroendovascular fellowship training

neuroendovascular teleproctoring
A novel augmented reality (AR) platform (Proximie) has been successfully used to teleproctor a neuroendovascular fellow during complex interventional and diagnostic procedures. That is...

CRISP study indicates clinical benefit of non-paraesthesia-based approaches in burst SCS...

crisp study scs
The CRISP (Comparison of paraesthesia mapping to anatomic midline-based burst programming strategies) study, published in Neuromodulation: Technology at the Neural Interface, has found that...

Sensome begins first-in-human trial of AI-powered stroke guidewire

sensome clot out
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...

NeuroNews issue 43 – US

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies – including new insights on the Flow redirection endoluminal device (FRED;...

NeuroNews issue 43 – EU

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies - including new insights on the Flow redirection endoluminal device (FRED;...

TCAR may be associated with favourable outcomes for treatment of restenotic...

tcar restenotic carotid lesions
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies

flow diverter devices
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....

Neuromod Devices appoints Diarmuid Flavin as COO to boost expansion of...

Diarmuid Flavin
Neuromod Devices has announced the appointment of Diarmuid Flavin as chief operating officer (COO). Flavin brings more than 25 years of global leadership experience...

Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...

swift-direct trial thrombectomy
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...

Flying intervention teams lead to higher EVT rates and reduced time...

flying intervention teams stroke
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...

NeuroOne Medical Technologies gains FDA 510(k) clearance for Evo SEEG electrode

neuroone evo technology
NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with neurological disorders—has announced that it has received US Food...

NeuroNews’ top 10 most popular stories of August 2021

An exclusive interview covering a novel endovascular treatment option for communicating hydrocephalus (CH), the latest research involving deep brain stimulation (DBS) therapies, and data...

ESOC 2021: AI can calculate personalised risk of having another stroke

Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...

ESOC 2021: Non-traditional risk factors for heart attack and stroke rising...

stroke risk factors
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional risk factors for heart attack and stroke—are rising more steeply among women than men,...

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

vivistim system
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...

Presidio Medical publishes clinical and preclinical research on ULF neuromodulation therapy

ulf neuromodulation
Presidio Medical has announced that research involving its novel ultra-low frequency (ULF) neuromodulation therapy has been published in Science Translational Medicine. The publication, titled...

DTM SCS: A unique, tailored and highly effective therapy option for...

dtm scs therapy
Michael Fishman (Wilmington, USA) discusses the benefits of Differential Target Multiplexed spinal cord stimulation (DTM SCS; Medtronic)—when compared to more conventional SCS therapy options—and...

Qure.ai lands second FDA clearance for AI-based brain scan technology

qure.ai
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...

Postoperative admission of adult craniotomy patients to neuroscience ward reduces length...

craniotomy neuroscience ward
Admitting adult craniotomy patients without significant comorbidities, who are expected to have a short length of stay, to the neuroscience ward has been associated...

Synchron announces US$10 million NIH grant for US COMMAND trial

synchron nih grant
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...

SyntheticMR and Siemens Healthineers extend collaboration with new license agreement

syntheticmr siemens healthineers
SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR's...

Neurosurgery with Surgical Theater’s VR and AR technologies set for first...

surgical theater israel
Rambam Healthcare Medical Center in Haifa, Israel is set to become the first medical centre in Israel to use virtual reality (VR) and augmented...

Behavioural interventions and more holistic approach signal “paradigm shift” in latest...

aha/asa secondary stroke prevention
In May 2021, the American Heart Association (AHA)/American Stroke Association (ASA) updated one of its flagship guidelines—the secondary prevention of stroke guideline—for the first...

Insightec announces Seoul National University Hospital is installing its Exablate Neuro...

exablate neuro india
Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro (Exablate 4000) platform—which uses focused ultrasound to ablate targets...

William Mack

william mack
William Mack is a professor of neurosurgery and vice-chair of academic affairs in the Department of Neurological Surgery at the University of Southern California...

Benefits of EVT for basilar artery occlusion “cannot be excluded” following...

basics evt trial
A randomised controlled trial (RCT) involving 300 patients found that functional outcomes among basilar artery occlusion stroke patients “did not differ significantly” with endovascular...

Michael Chen becomes 26th president of SNIS

michael chen snis president
Michael Chen, a neurointerventionist at Rush University Medical Center in Chicago, USA, has been named the president of the Society of NeuroInterventional Surgery (SNIS)...

Fluid Biotech raises US$4.7 million in oversubscribed seed funding round

fluid biotech
Fluid Biotech, a medical device start-up company based in Calgary, Canada, has announced the completion of an oversubscribed seed fundraising round totalling US$4.7 million—and...

Time is brain: Travelling stroke team enables faster treatment and better...

travelling stroke team
In a pilot programme in New York City, USA, a mobile interventional stroke team (MIST) travelled directly to patients to perform emergency stroke surgery...

Flow Neuroscience receives Series A funding to advance tDCS depression treatment

flow neuroscience funding
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...

SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology

spintech stage
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...

Phenox highlights benefits of longer stentriever devices with new study results

phenox longer stentriever
Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...

Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress

focused ultrasound neurotherapy
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...

FRED flow diverter safe and effective in treatment of “appropriately selected”...

fred flow diverter
The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...

Allegheny Health Network initiates clinical trial exploring use of DBS to...

dbs obesity treatment
A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...

NeuroNews’ top 10 most popular stories of July 2021

top 10 NeuroNews July
A new technology to help surgeons reduce the risk of aneurysm regrowth, Philips’ most recent contributions to the field of stroke care, and evidence...

Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study

dbs long-term effectiveness
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...

Synchron given green light to begin US study of endovascular brain-computer...

synchron nih grant
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...

Gender disparity in comprehensive stroke centre routing highlighted at SNIS 

women comprehensive stroke centre
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...

SNIS 2021: Remote stroke interventions raise several unique ethical challenges

remote stroke interventions
At the Society of NeuroInterventional Surgery’s 18th annual meeting (SNIS; July 26–29 2021, Colorado Springs, USA and virtual), Jeffrey Saver, professor of Neurology at...

Using new-generation CB-CT imaging tests may shorten time to surgery for...

Using a different type of computed tomography (CT) scan may reduce the time to essential surgery for patients with the deadliest kind of strokes—emergent...

Research shows new surgical technology may help reduce brain aneurysm regrowth

A new tool for treating brain aneurysms may protect artery blood flow during surgery and reduce the risk of aneurysm regrowth, according to a...

Black stroke patients undergo neuroendovascular surgery less often than white patients,...

Black patients with stroke are less likely than white patients to undergo a potentially lifesaving, minimally-invasive thrombectomy procedure to remove blood clots from arteries...

Neuro42 closes US$6.5 million Series A financing round

neuro42
Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has announced the close of a US$6.5 million Series A...

Race among factors that predict how quickly patients get to stroke...

stroke care centres
Race, in combination with other factors, predicted how quickly individuals with stroke got to care centres to receive necessary neuroendovascular surgery, including thrombectomy, according...

Cerenovus to unveil new data and showcase stroke care innovations at...

cerenovus stroke care
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

carotid disease stenting
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...

Omniscient Neurotechnology launches Quicktome brain-mapping platform following FDA clearance

quicktome omniscient neurotechnology
Omniscient Neurotechnology has received US Food and Drug Administration (FDA) 510(k) clearance for Quicktome—a digital brain-mapping platform that allows neurosurgeons to visualise and understand...

Omniscient Neurotechnology raises AUD$40 million in Series B financing

Omniscient Neurotechnology
Omniscient Neurotechnology, a Sydney-based brain-mapping technology company, has announced the completion of a AUD$40 million Series B financing round. The funding will allow Omniscient...

Nevro announces FDA approval of 10kHz high-frequency SCS therapy for painful...

nevro senza
Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system for the treatment of chronic pain associated with...

NeuroNews issue 42 – US

Highlights:  Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial Why the...

NeuroNews issue 42 – EU

Highlights:  Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial Why the...

ASA highlights value of comprehensive, patient-centred primary care after stroke

primary stroke care ASA
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...

How stimulation is changing the future of mental health treatment

tdcs mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...

Brainomix launches AI stroke software across Poland under POLKARD initiative

brainomix poland
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...

BlueWind Medical enrols 100th patient in OASIS study of Renova iStim...

renova istim
BlueWind Medical, a company making neuromodulation medical devices for the treatment of overactive bladder, has announced that the 100th patient has been enrolled in...

Repeated clot retrieval attempts linked to poorer functional outcome in acute...

repeated clot retrieval stroke
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...

Philips enrols first patient in WE-TRUST stroke study to assess new...

WE-TRUST study philips
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...

Robocath, Rennes University Hospital partner with Philips France to research stroke...

robocath stroke research
Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...

Insightec announces approval of Exablate Neuro focused ultrasound platform in Singapore

exablate neuro singapore
Insightec has announced approval of its Exablate Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses...

Men and women respond equally well to spinal cord and DRG...

spinal cord stimulation men women
In a study intended to explore gender differences in patients with failed back surgery syndrome (FBSS) or chronic visceral pain, men and women have...

Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...

neuros quest study
Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...

NeuroNews’ top 10 most popular stories of June 2021

neuronews top 10
Fresh evidence on the differences between directional and omnidirectional deep brain stimulation (DBS), as well as regulatory approvals for a new reperfusion catheter and...

Viz.ai receives CE mark to bring AI-powered stroke care software to...

viz.ai ce mark
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...

Mainstay Medical launches implantable restorative neurostimulation system in USA

mainstay reactiv8
Mainstay Medical has announced the limited US commercial launch of ReActiv8, its implantable restorative neurostimulation system to treat intractable chronic low back pain. The...

Flow diverter study with virtual participants “as effective as traditional clinical...

virtual flow diverter trials
A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...

New Stroke Association report to “shine a light” on stroke care’s...

stroke association priorities
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...

Epipole joins €1.1 million AI project to diagnose intracranial pressure

epipole
Video retinal imaging company Epipole has announced it has begun working on a €1.1 million collaborative project to develop a technology solution for the...

Penumbra receives FDA clearance for RED 62 reperfusion catheter

penumbra red 62
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED 62 reperfusion catheter—the latest addition to the...

Stroke and heart condition patients want virtual healthcare to continue post...

virtual stroke care
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...

Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation

sensome clot out
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...

Neuromodulation device for treating MS-related gait deficit receives FDA authorisation

pons fda approval
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...

Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and...

pipeline embolization device
The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...

Medtronic announces FDA approval of recharge-free Vanta spinal cord stimulation implant

medtronic vanta
Medtronic has received US Food and Drug Administration (FDA) approval for Vanta—a high-performance, recharge-free implantable neurostimulator (INS) with a device life that can be...

Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...

directional dbs
Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...

Mitchell Elkind

mitchell elkind
Mitchell Elkind is a professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and chief of the Division of Neurology Clinical Outcomes Research and Population...

FDA approves “first-of-its-kind” SenSight Directional Lead System for DBS therapy

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic has announced US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System, which is used...

New algorithm could enable next-generation deep brain stimulation devices

next-generation dbs devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...

Vesalio secures Class A funding to bolster stroke treatment portfolio

vesalio series a funding
Vesalio has successfully secured a Class A financing round. The company claims this funding will be utilised to support its ongoing US Investigational Device...

Higher incidence of severe stroke found in COVID-19 patients

covid-19 severe stroke
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...

NeuroNews’ top 10 most popular stories of May 2021

neuronews top 10
New industry partnerships, the potential for energy savings in neuromodulation and the contentious topic of vertebral artery stenting were among the top stories that...

Avicenna.AI receives CE mark for AI tool to assess stroke severity

stroke severity assessment ai
Medical imaging AI specialist Avicenna.AI has received CE mark certification for its CINA ASPECTS AI tool for stroke severity assessment. CINA ASPECTS automatically processes...

Clinical improvements seen following transvenous paraspinal vein embolisation for CSF hypotension

csf hypotension
A case series to assess transvenous paraspinal vein embolisation of cerebrospinal fluid (CSF)-venous fistulas—a novel treatment approach for spontaneous intracranial hypotension (SIH)—has resulted in...

RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...

RapidAI
RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...

Livestreamed procedures close distance between clinicians and trainees during pandemic

livestreamed surgeries
Phil Taussky outlines a simple yet effective livestreaming platform that holds benefits for neurosurgeons during the ongoing COVID-19 crisis. One of the challenges faced by...

HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter

hemo bioengineering afentta
HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...

Prevention based on first stroke cause can reduce risk of subsequent...

aha stroke prevention guidelines
Identifying the cause of a stroke or transient ischaemic attack (TIA)—sometimes called a “mini-stroke”—can lead to specific prevention strategies to reduce the risk of...

Noninferiority of thrombectomy alone further demonstrated in acute ischaemic stroke treatment

mechanical thrombectomy alone
The noninferiority of mechanical thrombectomy alone—compared to mechanical thrombectomy plus intravenous tissue plasminogen activator (IV-tPA)—for the treatment of acute ischaemic stroke has been demonstrated...

Study shows “major energy savings” can be achieved in spinal cord...

spinal cord stimulation chronic pain
The results of the HALO (High and low frequency options) study, which are published online in the scientific journal Neuromodulation: Technology at the Neural...

Chordate Medical receives CE mark to treat chronic migraine with neuromodulation...

chordate medical
Chordate Medical has received a CE marking that permits its Kinetic Oscillation Stimulation (KOS) technology to be marketed, sold and used for the treatment...

Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...

viz.ai medtronic
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...

First annual World Stroke Thrombectomy Day to be announced by SVIN...

world stroke thrombectomy day
The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2020+ Initiative (MT2020+) will announce the first annual World Stroke Thrombectomy Day at the...

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

vesalio
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...

rTMS found to be “well-accepted” for therapeutic use in psychiatric populations

rtms therapy georgia stillianesis
Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...

Perfuze announces CE mark and treats first patients with Millipede 088...

perfuze millipede 088
Neurovascular medical device company Perfuze has announced that the first five acute ischaemic stroke patients have been treated with its Millipede 088 clot aspiration...

Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net

perflow medical stream17 device
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...

CX 2021: Stenting should be reserved for the extracranial vertebral arteries...

vertebral artery stenting
Stenting is something that, for now at least, should be considered in the extracranial vertebral arteries only—and not the intracranial arteries—for symptomatic atherosclerotic stenosis,...

First US ischaemic stroke patients treated with Rapid Medical’s novel clot...

rapid medical TIGERTRIEVER
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...

IpsiHand System: New device for facilitating stroke rehabilitation gains FDA approval

IpsiHand System
The US Food and Drug Administration (FDA) has authorised marketing of a new device indicated for use in patients aged 18 and older undergoing...

Case report indicates 3D black blood vessel wall imaging can predict...

dr mohd fandi black blood vessel wall imaging
The early findings from a case report have highlighted the potential held by 3D black blood vessel wall post-contrast imaging to predict the outcomes...

Medtronic and Surgical Theater to provide first real-time AR platform for...

complex cranial procedures
Medtronic will partner with American health technology firm Surgical Theater to provide the first augmented reality (AR) platform for use in real time during...

UK charity funds “world-first” study into long-term COVID-19 impact on stroke

stroke association priorities
Leading UK charity the Stroke Association is funding what it claims will be the world’s first study to determine the long-term impact of COVID-19...

First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic...

lvo stroke diagnosis mindrhythm
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...

Thrombolysis versus thrombectomy: Honours even between basilar occlusion treatments in CX...

basilar artery occlusion treatments
Thrombolysis is considered as effective as mechanical thrombectomy for the treatment of basilar artery occlusion (BAO)—despite existing evidence on both intervention options being limited....

Medtronic gains FDA approval to trial implantable tibial neuromodulation device

medtronic implantable tibial neuromodulation device
Medtronic has announced approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate its...